This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncol. 2021 Aug 2; 23(8):1231–51.LouisDNPerryAWesselingPBratDJCreeIAFigarella-BrangerD.The 2021 WHO Classification of Tumors of the Central Nervous System: a summary..2021Aug2;23(8):1231–51.Search in Google Scholar
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol (Berl). 2016 Jun;131(6):803–20.LouisDNPerryAReifenbergerGvon DeimlingAFigarella-BrangerDCaveneeWK.The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary..2016Jun;131(6):803–20.Search in Google Scholar
Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008 Jul 31;359(5):492–507.WenPYKesariS.Malignant gliomas in adults..2008Jul31;359(5):492–507.Search in Google Scholar
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10;352(10): 987–96.StuppRMasonWPvan den BentMJWellerMFisherBTaphoornMJB.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma..2005Mar10;352(10):987–96.Search in Google Scholar
Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview. Eur J Med Chem. 2020 May 15;194:112260.MondalSAdhikariNBanerjeeSAminSAJhaT.Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview..2020May15;194:112260.Search in Google Scholar
Fujioka H, Dairyo Y, Yasunaga KI, Emoto K. Neural functions of matrix metalloproteinases: plasticity, neurogenesis, and disease. Biochem Res Int. 2012;2012:789083.FujiokaHDairyoYYasunagaKIEmotoK.Neural functions of matrix metalloproteinases: plasticity, neurogenesis, and disease..2012;2012:789083.Search in Google Scholar
Singh D, Srivastava SK, Chaudhuri TK, Upadhyay G. Multifaceted role of matrix metalloproteinases (MMPs). Front Mol Biosci. 2015 May 13;2:19.SinghDSrivastavaSKChaudhuriTKUpadhyayG.Multifaceted role of matrix metalloproteinases (MMPs)..2015May13;2:19.Search in Google Scholar
Dibdiakova K, Svec A, Majercikova Z, Adamik M, Grendar M, Vana J, et al. Associations between matrix metalloproteinase, tissue inhibitor of metalloproteinase and collagen expression levels in the adjacent rectal tissue of colorectal carcinoma patients. Mol Clin Oncol. 2022 Feb;16(2):41.DibdiakovaKSvecAMajercikovaZAdamikMGrendarMVanaJ.Associations between matrix metalloproteinase, tissue inhibitor of metalloproteinase and collagen expression levels in the adjacent rectal tissue of colorectal carcinoma patients..2022Feb;16(2):41.Search in Google Scholar
Lukaszewicz-Zajac M, Mroczko B, Kornhuber J, Lewczuk P. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS). J Neural Transm Vienna Austria 1996. 2014 May;121(5):469–77.Lukaszewicz-ZajacMMroczkoBKornhuberJLewczukP.Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS)..2014May;121(5):469–77.Search in Google Scholar
Jiguet-Jiglaire C, Boissonneau S, Denicolai E, Hein V, Lasseur R, Garcia J, et al. Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study. Acta Neuropathol Commun. 2022 Jan 3;10:1.Jiguet-JiglaireCBoissonneauSDenicolaiEHeinVLasseurRGarciaJ.Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study..2022Jan3;10:1.Search in Google Scholar
Noёl A, Jost M, Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol. 2008 Feb;19(1):52–60.NoёlAJostMMaquoiE.Matrix metalloproteinases at cancer tumor-host interface..2008Feb;19(1):52–60.Search in Google Scholar
Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie. 2005 Mar 1;87(3):287–97.Turpeenniemi-HujanenT.Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers..2005Mar1;87(3):287–97.Search in Google Scholar
Rempe RG, Hartz AMS, Bauer B. Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2016 Sep;36(9):1481–507.RempeRGHartzAMSBauerB.Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers..2016Sep;36(9):1481–507.Search in Google Scholar
Dobra G, Gyukity-Sebestyén E, Bukva M, Harmati M, Nagy V, Szabó Z, et al. MMP-9 as Prognostic Marker for Brain Tumours: A Comparative Study on Serum-Derived Small Extracellular Vesicles. Cancers. 2023 Jan 24;15(3):712.DobraGGyukity-SebestyénEBukvaMHarmatiMNagyVSzabóZ.MMP-9 as Prognostic Marker for Brain Tumours: A Comparative Study on Serum-Derived Small Extracellular Vesicles..2023Jan24;15(3):712.Search in Google Scholar
Zhou W, Yu X, Sun S, Zhang X, Yang W, Zhang J, et al. Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence. Biomed Pharmacother Biomedecine Pharmacother. 2019 Oct;118:109369.ZhouWYuXSunSZhangXYangWZhangJ.Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence..2019Oct;118:109369.Search in Google Scholar
Mannello F, Medda V. Nuclear localization of matrix metalloproteinases. Prog Histochem Cytochem. 2012 Mar;47(1):27–58.MannelloFMeddaV.Nuclear localization of matrix metalloproteinases..2012Mar;47(1):27–58.Search in Google Scholar
Hsieh WT, Yeh WL, Cheng RY, Lin C, Tsai CF, Huang BR, et al. Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme. J Neurooncol. 2014 Jun;118(2):257–69.HsiehWTYehWLChengRYLinCTsaiCFHuangBR.Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme..2014Jun;118(2):257–69.Search in Google Scholar
Tsai CF, Yeh WL, Chen JH, Lin C, Huang SS, Lu DY. Osthole suppresses the migratory ability of human glioblastoma multiforme cells via inhibition of focal adhesion kinase-mediated matrix metalloproteinase-13 expression. Int J Mol Sci. 2014 Mar 4;15(3):3889–903.TsaiCFYehWLChenJHLinCHuangSSLuDY.Osthole suppresses the migratory ability of human glioblastoma multiforme cells via inhibition of focal adhesion kinase-mediated matrix metalloproteinase-13 expression..2014Mar4;15(3):3889–903.Search in Google Scholar
Strand S, Vollmer P, van den Abeelen L, Gottfried D, Alla V, Heid H, et al. Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells. Oncogene. 2004 Apr 29; 23(20):3732–6.StrandSVollmerPvan den AbeelenLGottfriedDAllaVHeidH.Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells..2004Apr29;23(20):3732–6.Search in Google Scholar
Ulasov I, Yi R, Guo D, Sarvaiya P, Cobbs C. The emerging role of MMP14 in brain tumorigenesis and future therapeutics. Biochim Biophys Acta. 2014 Aug;1846(1):113–20.UlasovIYiRGuoDSarvaiyaPCobbsC.The emerging role of MMP14 in brain tumorigenesis and future therapeutics..2014Aug;1846(1):113–20.Search in Google Scholar
Quintero-Fabián S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Argáez V, Lara-Riegos J, et al. Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Front Oncol. 2019 Dec 6;9:1370.Quintero-FabiánSArreolaRBecerril-VillanuevaETorres-RomeroJCArana-ArgáezVLara-RiegosJ.Role of Matrix Metalloproteinases in Angiogenesis and Cancer..2019Dec6;9:1370.Search in Google Scholar
Sounni NE, Paye A, Host L, Noёl A. MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis. Front Pharmacol. 2011;2:111.SounniNEPayeAHostLNoёlA.MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis..2011;2:111.Search in Google Scholar
Lee H, Chang KW, Yang HY, Lin PW, Chen SU, Huang YL. MT1-MMP regulates MMP-2 expression and angiogenesis-related functions in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2013 Jul 26;437(2):232–8.LeeHChangKWYangHYLinPWChenSUHuangYL.MT1-MMP regulates MMP-2 expression and angiogenesis-related functions in human umbilical vein endothelial cells..2013Jul26;437(2):232–8.Search in Google Scholar
Kesanakurti D, Chetty C, Dinh DH, Gujrati M, Rao JS. Role of MMP-2 in the Regulation of IL-6/Stat3 Survival Signaling via Interaction With 5 1 Integrin in glioma. Oncogene. 2013 Jan 17;32(3): 327–40.KesanakurtiDChettyCDinhDHGujratiMRaoJS.Role of MMP-2 in the Regulation of IL-6/Stat3 Survival Signaling via Interaction With 5 1 Integrin in glioma..2013Jan17;32(3):327–40.Search in Google Scholar
Kesanakurti D, Chetty C, Rajasekhar Maddirela D, Gujrati M, Rao JS. Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma. Cell Death Dis. 2012 Dec;3(12):e445.KesanakurtiDChettyCRajasekhar MaddirelaDGujratiMRaoJS.Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma..2012Dec;3(12):e445.Search in Google Scholar
Karin M, Chang L. AP-1—glucocorticoid receptor crosstalk taken to a higher level. J Endocrinol. 2001 Jun;169(3):447–51.KarinMChangL.AP-1—glucocorticoid receptor crosstalk taken to a higher level..2001Jun;169(3):447–51.Search in Google Scholar
Botkjaer KA, Kwok HF, Terp MG, Karatt-Vellatt A, Santamaria S, McCafferty J, et al. Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo. Oncotarget. 2016 Mar 29;7(13):16773–92.BotkjaerKAKwokHFTerpMGKaratt-VellattASantamariaSMcCaffertyJ.Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo..2016Mar29;7(13):16773–92.Search in Google Scholar
Pruijt JF, Fibbe WE, Laterveer L, Pieters RA, Lindley IJ, Paemen L, et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10863–8.PruijtJFFibbeWELaterveerLPietersRALindleyIJPaemenL.Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9)..1999Sep14;96(19):10863–8.Search in Google Scholar
Murphy G. Tissue inhibitors of metalloproteinases. Genome Biol. 2011 Nov 11;12(11):233.MurphyG.Tissue inhibitors of metalloproteinases..2011Nov11;12(11):233.Search in Google Scholar
Westermarck J, Kähäri VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J Off Publ Fed Am Soc Exp Biol. 1999 May;13(8):781–92.WestermarckJKähäriVM.Regulation of matrix metalloproteinase expression in tumor invasion..1999May;13(8):781–92.Search in Google Scholar
Chau Y, Tan FE, Langer R. Synthesis and Characterization of Dextran-Peptide-Methotrexate Conjugates for Tumor Targeting via Mediation by Matrix Metalloproteinase II and Matrix Metalloproteinase IX. Bioconjug Chem. 2004 Jul 1;15(4):931–41.ChauYTanFELangerR.Synthesis and Characterization of Dextran-Peptide-Methotrexate Conjugates for Tumor Targeting via Mediation by Matrix Metalloproteinase II and Matrix Metalloproteinase IX..2004Jul1;15(4):931–41.Search in Google Scholar
Hua D, Tang L, Wang W, Tang S, Yu L, Zhou X, et al. Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable Peptide. Adv Sci. 2021;8(3):2001960.HuaDTangLWangWTangSYuLZhouX.Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable Peptide..2021;8(3):2001960.Search in Google Scholar
Vandenbroucke RE, Libert C. Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov. 2014 Dec;13(12):904–27.VandenbrouckeRELibertC.Is there new hope for therapeutic matrix metalloproteinase inhibition?.2014Dec;13(12):904–27.Search in Google Scholar